These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10952786)

  • 41. Selenium effects on prostate cell growth.
    Menter DG; Sabichi AL; Lippman SM
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1171-82. PubMed ID: 11097224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of ARG kinase activity by STI571 induces cell cycle arrest through up-regulation of CDK inhibitor p18/INK4c.
    Nishimura N; Furukawa Y; Sutheesophon K; Nakamura M; Kishi K; Okuda K; Sato Y; Kano Y
    Oncogene; 2003 Jun; 22(26):4074-82. PubMed ID: 12821941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single amino acid (arginine) restriction: growth and death of cultured HeLa and human diploid fibroblasts.
    Wheatley DN; Scott L; Lamb J; Smith S
    Cell Physiol Biochem; 2000; 10(1-2):37-55. PubMed ID: 10846151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures.
    Philip R; Campbell E; Wheatley DN
    Br J Cancer; 2003 Feb; 88(4):613-23. PubMed ID: 12592378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arginine catabolism, liver extracts and cancer.
    Wheatley DN; Campbell E
    Pathol Oncol Res; 2002; 8(1):18-25. PubMed ID: 11994758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arginase-induced cell death pathways and metabolic changes in cancer cells are not altered by insulin.
    Chew HY; Cvetkovic G; Tepic S; Wells JW
    Sci Rep; 2024 Feb; 14(1):4112. PubMed ID: 38374190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [General remarks of methods for analyzing proliferative characteristics of the cells].
    Nakamura S
    Rinsho Byori; 1993 Jun; Suppl 94():89-103. PubMed ID: 8361012
    [No Abstract]   [Full Text] [Related]  

  • 48. Arginine deprivation as a treatment approach targeting cancer cell metabolism and survival: A review of the literature.
    Assi G; Faour WH
    Eur J Pharmacol; 2023 Aug; 953():175830. PubMed ID: 37277030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumour growth dynamics.
    Watson JV
    Br Med Bull; 1991 Jan; 47(1):47-63. PubMed ID: 1863848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting arginine metabolism pathway to treat arginine-dependent cancers.
    Qiu F; Huang J; Sui M
    Cancer Lett; 2015 Aug; 364(1):1-7. PubMed ID: 25917076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arginine deprivation as a targeted therapy for cancer.
    Feun L; You M; Wu CJ; Kuo MT; Wangpaichitr M; Spector S; Savaraj N
    Curr Pharm Des; 2008; 14(11):1049-57. PubMed ID: 18473854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
    Cheng PN; Lam TL; Lam WM; Tsui SM; Cheng AW; Lo WH; Leung YC
    Cancer Res; 2007 Jan; 67(1):309-17. PubMed ID: 17210712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of β-actin arginylation.
    Pavlyk I; Rzhepetskyy Y; Jagielski AK; Drozak J; Wasik A; Pereverzieva G; Olchowik M; Kunz-Schugart LA; Stasyk O; Redowicz MJ
    Amino Acids; 2015 Jan; 47(1):199-212. PubMed ID: 25362567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer metabolism: looking forward.
    Martínez-Reyes I; Chandel NS
    Nat Rev Cancer; 2021 Oct; 21(10):669-680. PubMed ID: 34272515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Emerging Hallmarks of Cancer Metabolism.
    Pavlova NN; Thompson CB
    Cell Metab; 2016 Jan; 23(1):27-47. PubMed ID: 26771115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression.
    Li Z; Zhang H
    Cell Mol Life Sci; 2016 Jan; 73(2):377-92. PubMed ID: 26499846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arginine Is a Novel Drug Target for Arginine Decarboxylase in Human Colorectal Cancer Cells.
    Wei X; Chow HY; Chong HC; Leung SL; Ho MK; Lee MY; Leung YC
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dietary Manipulation of Amino Acids for Cancer Therapy.
    Jiménez-Alonso JJ; López-Lázaro M
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arginine deiminase produced by lactic acid bacteria as a potent anti-cancer drug.
    Thakker DP; Narayanan R
    Med Oncol; 2023 May; 40(6):175. PubMed ID: 37171497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot study: Metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients.
    Muller Bark J; Karpe AV; Doecke JD; Leo P; Jeffree RL; Chua B; Day BW; Beale DJ; Punyadeera C
    Cancer Med; 2023 May; 12(10):11427-11437. PubMed ID: 37031458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.